Ursodeoxycholic Acid Attenuates Endoplasmic Reticulum Stress-Related Retinal Pericyte Loss in Streptozotocin-Induced Diabetic Mice

Journal of Diabetes Research - Tập 2017 - Trang 1-10 - 2017
Yoo-Ri Chung1, Jeong A Choi2, Jae‐Young Koh3,2, Young Hee Yoon1
1Department of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
2Neural Injury Research Center, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
3Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

Tóm tắt

Loss of pericytes, an early hallmark of diabetic retinopathy (DR), results in breakdown of the blood-retinal barrier. Endoplasmic reticulum (ER) stress may be involved in this process. The purpose of this study was to examine the effects of ursodeoxycholic acid (UDCA), a known ameliorator of ER stress, on pericyte loss in DR of streptozotocin- (STZ-) induced diabetic mice. To assess the extent of DR, the integrity of retinal vessels and density of retinal capillaries in STZ-induced diabetic mice were evaluated. Additionally, induction of ER stress and the unfolded protein response (UPR) were assessed in diabetic mice and human retinal pericytes exposed to advanced glycation end products (AGE) or modified low-density lipoprotein (mLDL). Fluorescein dye leakage during angiography and retinal capillary density were improved in UDCA-treated diabetic mice, compared to the nontreated diabetic group. Among the UPR markers, those involved in the protein kinase-like ER kinase (PERK) pathway were increased, while UDCA attenuated UPR in STZ-induced diabetic mice as well as AGE- or mLDL-exposed retinal pericytes in culture. Consequently, vascular integrity was improved and pericyte loss reduced in the retina of STZ-induced diabetic mice. Our findings suggest that UDCA might be effective in protecting against DR.

Từ khóa


Tài liệu tham khảo

10.2174/157339910793360815

10.1111/dme.12119

10.1007/s00592-012-0449-3

10.4239/wjd.v6.i2.312

10.1167/iovs.15-17334

10.1155/2015/757412

10.1016/j.preteyeres.2011.05.002

10.1007/s00125-012-2692-0

10.1055/s-2005-861361

10.1111/j.1463-1326.2007.00795.x

10.2337/db08-0325

10.1016/j.preteyeres.2013.02.001

10.1677/JME-08-0011

10.1016/s1056-8727(02)00271-4

10.1053/meta.2002.34703

10.1194/jlr.M045401

10.1016/j.exer.2007.10.013

10.1016/j.febslet.2009.04.007

10.2147/vhrm.2008.04.01.115

10.1155/2012/589589

2013, Mechanisms of ER stress in retinal diseases, 529

10.1007/s12177-011-9075-5

10.1080/02713680600966785

10.1146/annurev.biochem.73.011303.074134

10.1007/978-1-4614-0631-0_37

10.1371/journal.pone.0024245

10.1016/j.neuroscience.2013.08.053

10.1007/s00592-009-0170-z

10.2337/diabetes.49.12.2160

2000, Investigative Ophthalmology and Visual Science, 41, 1176

10.1111/j.1440-1797.2007.00796.x

10.1002/0471141755.ph0547s40

10.1089/jop.2010.0012

10.1155/2016/3789217

10.1155/2013/106594

10.1167/iovs.13-11915

10.1101/pdb.prot082545

10.1038/nprot.2006.238

10.1016/j.ophtha.2014.07.019

10.1007/s00125-013-2986-x

10.2337/dc11-1909

10.1042/CS20120588

10.1038/sj.eye.6701476

2004, Bulletin of the World Health Organization, 82, 844

10.1056/nejmoa1001288

10.1001/archopht.1995.01100010038019

10.1016/S0039-6257(02)00391-0

10.1155/2012/507986

10.1038/cddis.2013.517

10.1016/j.yexcr.2013.01.012

10.1016/j.lfs.2006.03.020

10.1126/science.1128294

10.1016/j.exer.2014.03.005

10.1038/labinvest.2016.44